← Alle mensen

TW

Thomas Wehler

2 publicaties

PubMed → Google Scholar →

Publicaties op Oncologisch.com

Subcutaan versus IV amivantamab plus lazertinib bij EGFR-gemuteerd NSCLC: PALOMA-3

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 20 oktober 2024

PROs van atezolizumab plus chemotherapie bij NSCLC: IMpower150 analyse

Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 1 augustus 2020